E-LIB Suche - Ergebnisse für: Sagiv-Barfi, Idit

1

An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releas..:

Haabeth, Ole A. W. ; Lohmeyer, Julian J. K. ; Sallets, Adrienne...
ACS Central Science. 7 (2021) 7 - p. 1191-1204 , 2021

Link: https://doi.org/10.1021/..

2

Supporting the Next Generation of Scientists to Lead Cancer..:

Alspach, Elise ; Chow, Ryan D. ; Demehri, Shadmehr...
Cancer Immunology Research. 9 (2021) 11 - p. 1245-1251 , 2021

Link: https://doi.org/10.1158/..

3

S101, an Inhibitor of Proliferating T Cells, Rescues Mice F..:

Shir, Alexei ; Klein, Shoshana ; Sagiv-Barfi, Idit...
The Journal of Infectious Diseases. 217 (2017) 2 - p. 288-297 , 2017

Link: https://doi.org/10.1093/..

4

Therapeutic antitumor immunity by checkpoint blockade is en..:

Sagiv-Barfi, Idit ; Kohrt, Holbrook E. K. ; Czerwinski, Debra K....
Proceedings of the National Academy of Sciences of the United States of America. 112 (2015) 9 - p. E966-E972 , 2015

Link: https://www.jstor.org/st..

5

Therapeutic antitumor immunity by checkpoint blockade is en..:

Sagiv-Barfi, Idit ; Kohrt, Holbrook E. K. ; Czerwinski, Debra K....
Proceedings of the National Academy of Sciences. 112 (2015) 9 - p. , 2015

Link: https://doi.org/10.1073/..

6

Radiotherapy and Toll-Like Receptor Agonists:

Marabelle, Aurelien ; Filatenkov, Alex ; Sagiv-Barfi, Idit.
Seminars in Radiation Oncology. 25 (2015) 1 - p. 34-39 , 2015

Link: https://doi.org/10.1016/..

7

Design, synthesis, and evaluation of quinazoline T cell pro..:

Sagiv-Barfi, Idit ; Weiss, Ester ; Levitzki, Alexander
Bioorganic & Medicinal Chemistry. 18 (2010) 17 - p. 6404-6413 , 2010

Link: https://doi.org/10.1016/..

8

Targeted TLR9 Agonist Elicits Effective Antitumor Immunity ..:

Miller, Caitlyn L ; Sagiv-Barfi, Idit ; Neuhöfer, Patrick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315437/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Intratumoral immunotherapy relies on B and T cell collabora..:

Sagiv-Barfi, Idit ; Czerwinski, Debra K ; Shree, Tanaya..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254330/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Systemic delivery of a targeted synthetic immunostimulant t..:

Miller, Caitlyn L ; Sagiv-Barfi, Idit ; Neuhöfer, Patrick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134376/. , 2022

Link: http://www.ncbi.nlm.nih...

11

An mRNA SARS-CoV-2 vaccine employing a novel delivery vehic..:

Haabeth, Ole A.W ; Lohmeyer, Julian J.K ; Sallets, Adrienne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057237/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Supporting the next generation of scientists to lead cancer..:

Alspach, Elise ; Chow, Ryan D ; Demehri, Shadmehr...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644410/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Targeting CD137 enhances the efficacy of cetuximab:

Kohrt, Holbrook E ; Colevas, A. Dimitrios ; Houot, Roch...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546445/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Eradication of spontaneous malignancy by local immunotherap:

Sagiv-Barfi, Idit ; Czerwinski, Debra K ; Levy, Shoshana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997264/. , 2018

Link: http://www.ncbi.nlm.nih...

15

Therapeutic antitumor immunity by checkpoint blockade is en..:

Sagiv-Barfi, Idit ; Kohrt, Holbrook E. K ; Czerwinski, Debra K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352777/. , 2015

Link: http://www.ncbi.nlm.nih...